This trust offers the following services:

• Acute services:
• Specialist colorectal surgeon on-call at all times
• On-site bowel stenting facilities

• Diagnostic and pre-operative services:
• On-site PET-CT facilities
• On-site Cardio-Pulmonary Exercise Testing (CPET) facilities
• Routine Genetic Testing for Lynch Syndrome

• Surgical services:
• Robotic surgery

• Advanced disease services:
• Dedicated Specialist Advanced Nurse
• Dedicated Specialist Advanced MDT
• Dedicated Specialist Advanced Outpatient Clinic
• Complex vascular reconstruction
• Distal sacrectomy
• High sacrectomy
• Extended lymphadenectomy
• HIPEC/cytoreductive surgery

• Support service facilities:
• Dedicated nurses for ERAS services
• Availability of 24 hour palliative care advice
• 7-day access to face-to-face palliative care services

All Patients:	Trust	Network	National
Number of patients in Audit	298	1558	35779
Case ascertainment (%)	Good	Fair	Good
Data completeness of:
– Pre-treatment TNM (%)	85	81	86
– Performance status (%)	100	78	89

Patients having major resection:	Trust	Network	National
Number of patients in Audit	198	848	19631
ASA grade 1 (%)	6	22	9
ASA grade 2 (%)	64	52	53
ASA grade 3 (%)	27	21	31
ASA grade 4+ (%)	1	1	2
ASA grade not recorded (%)	3	4	4
Data completeness of:
7 Audit items for risk-adjustment (%)	94	93	87

All Patients:	Trust	Network	National
Number of patients in Audit	298	1558	35779
Seen by Clinical Nurse Specialist (%)	96	85	88

Patients having major resection:	Trust	Network	National
Number of patients in Audit	198	848	19614
Distant metastases (%)	5	6	5
Urgent or emergency surgery (%)	10	10	15
At least 12 lymph nodes excised (%)	96	93	84
Laparoscopic surgery attempted (%)	51	63	72
Risk-adjusted length of stay > 5 days (%)	73	74	55

Patients having major resection for stage III colon cancer:	Trust	Network	National
Number of patients in audit	103	N/A	10747
Adjuvant chemotherapy (%)	61	N/A	62

Patients receiving chemotherapy after major resection for stage III colon cancer:	Trust	Network	National
Number of patients in audit	39	N/A	6608
Severe acute toxicity after adjuvant chemotherapy (%)	20	N/A	22

Patients having major resection:	Trust	Network	National
Number of patients in Audit	57	N/A	4251
Neoadjuvant therapy (%)	41	N/A	33
Circumferential resection margin: Recorded (%)	100	98	89
Circumferential resection margin: Negative (%)	93	94	83
Rectal volume	86	N/A	4377

Patients in APER/Hartmanns estimate:	Trust	Network	National
Number of patients in APER/Hartmanns estimate	299	985	19644
APER/Hartmanns (%)	39	31	37